Your browser doesn't support javascript.
loading
Clinical standards for the diagnosis, treatment and prevention of TB infection.
Migliori, G B; Wu, S J; Matteelli, A; Zenner, D; Goletti, D; Ahmedov, S; Al-Abri, S; Allen, D M; Balcells, M E; Garcia-Basteiro, A L; Cambau, E; Chaisson, R E; Chee, C B E; Dalcolmo, M P; Denholm, J T; Erkens, C; Esposito, S; Farnia, P; Friedland, J S; Graham, S; Hamada, Y; Harries, A D; Kay, A W; Kritski, A; Manga, S; Marais, B J; Menzies, D; Ng, D; Petrone, L; Rendon, A; Silva, D R; Schaaf, H S; Skrahina, A; Sotgiu, G; Thwaites, G; Tiberi, S; Tukvadze, N; Zellweger, J-P; D Ambrosio, L; Centis, R; Ong, C W M.
Affiliation
  • Migliori GB; Respiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
  • Wu SJ; Division of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System, Singapore City.
  • Matteelli A; Division of Infectious and Tropical Diseases, Spedali Civili University Hospital, Brescia, Italy, WHO Collaborating Centre for TB/HIV Collaborative Activities and for TB Elimination Strategy, University of Brescia, Brescia, Italy.
  • Zenner D; Centre for Global Public Health, Institute for Population Health Sciences, Queen Mary University, London, UK.
  • Goletti D; Translational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.
  • Ahmedov S; USAID, Bureau for Global Health, TB Division, Washington, DC, USA.
  • Al-Abri S; Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman.
  • Allen DM; Division of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System, Singapore City, Infectious Disease Translational Research Programme, Department of Medicine, National University of Singapore, Yong Loo Lin School of Medicine, Singapore City.
  • Balcells ME; Department of Infectious Diseases, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Garcia-Basteiro AL; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique, ISGlobal, Barcelona Centre for International Health Research, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
  • Cambau E; IAME UMR1137, INSERM, University of Paris, F-75018 Paris; AP-HP-Bichat Hospital, Associate laboratory of National Reference Center for Mycobacteria and Antimycobacterial Resistance, Paris, France.
  • Chaisson RE; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Chee CBE; Tuberculosis Control Unit, Tan Tock Seng Hospital, Singapore, Singapore.
  • Dalcolmo MP; Helio Fraga Reference Center, Oswaldo Cruz Foundation Ministry of Health, Rio de Janeiro, Brazil.
  • Denholm JT; Victorian Tuberculosis Program, Melbourne Health, Melbourne, VIC, Australia, Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
  • Erkens C; KNCV Tuberculosis Foundation, The Hague, The Netherlands.
  • Esposito S; Paediatric Clinic, Pietro Barilla Children´s Hospital, University of Parma, Parma, Italy.
  • Farnia P; Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Friedland JS; Institute for Infection and Immunity, St George´s, University of London, London, UK.
  • Graham S; Department of Paediatrics, Center for International Child Health, University of Melbourne, Melbourne, VIC, Australia, Murdoch Children´s Research Institute, Royal Children´s Hospital, Melbourne, Australia.
  • Hamada Y; Institute for Global Health, University College London, London, UK.
  • Harries AD; International Union Against Tuberculosis and Lung Disease, Paris, France, Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Kay AW; The Global Tuberculosis Program, Texas Children´s Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Kritski A; Academic Tuberculosis Program Center, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Manga S; Operational Center, Medecins Sans Frontieres (MSF), Paris, France.
  • Marais BJ; Department of Infectious Diseases and Microbiology, The Children´s Hospital at Westmead, Westmead, NSW, Australia, The University of Sydney Institute for Infectious Diseases, Sydney, NSW, Australia.
  • Menzies D; Montréal Chest Institute, Montréal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montréal, QC, Canada, McGill International Tuberculosis Centre, Montréal, QC, Canada.
  • Ng D; Infectious Diseases, National Centre for Infectious Diseases, Singapore.
  • Petrone L; Translational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.
  • Rendon A; Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias CIPTIR, University Hospital of Monterrey UANL (Universidad Autonoma de Nuevo Leon), Monterrey, Mexico.
  • Silva DR; Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
  • Schaaf HS; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Skrahina A; Republican Research and Practical Center for Pulmonology and Tuberculosis, Minsk, Belarus.
  • Sotgiu G; Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
  • Thwaites G; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Tiberi S; Department of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK, Blizard Institute, Queen Mary University of London, London, UK.
  • Tukvadze N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
  • Zellweger JP; TB Competence Center, Swiss Lung Association, Berne, Switzerland.
  • D Ambrosio L; Public Health Consulting Group, Lugano, Switzerland.
  • Centis R; Respiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
  • Ong CWM; Division of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System, Singapore City, Infectious Disease Translational Research Programme, Department of Medicine, National University of Singapore, Yong Loo Lin School of Medicine, Singapore City, Na
Int J Tuberc Lung Dis ; 26(3): 190-205, 2022 03 01.
Article in En | MEDLINE | ID: mdl-35197159
ABSTRACT

BACKGROUND:

Tuberculosis (TB) preventive therapy (TPT) decreases the risk of developing TB disease and its associated morbidity and mortality. The aim of these clinical standards is to guide the assessment, management of TB infection (TBI) and implementation of TPT.

METHODS:

A panel of global experts in the field of TB care was identified; 41 participated in a Delphi process. A 5-point Likert scale was used to score the initial standards. After rounds of revision, the document was approved with 100% agreement.

RESULTS:

Eight clinical standards were defined Standard 1, all individuals belonging to at-risk groups for TB should undergo testing for TBI; Standard 2, all individual candidates for TPT (including caregivers of children) should undergo a counselling/health education session; Standard 3, testing for TBI timing and test of choice should be optimised; Standard 4, TB disease should be excluded prior to initiation of TPT; Standard 5, all candidates for TPT should undergo a set of baseline examinations; Standard 6, all individuals initiating TPT should receive one of the recommended regimens; Standard 7, all individuals who have started TPT should be monitored; Standard 8, a TBI screening and testing register should be kept to inform the cascade of care.

CONCLUSION:

This is the first consensus-based set of Clinical Standards for TBI. This document guides clinicians, programme managers and public health officers in planning and implementing adequate measures to assess and manage TBI.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Latent Tuberculosis Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limits: Child / Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2022 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Latent Tuberculosis Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limits: Child / Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2022 Document type: Article Affiliation country: Italy